Naked mole-rats seem to have found nature’s cheat code for longevity. Scientists discovered that small tweaks in one of their ...
The poster for INSIGHT-003 and the Trial in Progress ePoster for TACTI-004 can be found at the Posters & Publications section of Immutep’s website.
New research into bowel cancer has identified ways to reactivate the immune system to help tackle the spread of the condition.
INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces that David Moss, Chief Executive Officer will participate in a Dermatologic Rare Disease Panel at ...
Novel combination including eftilagimod alfa (efti) in neoadjuvant setting drives 51.5% tumour hyalinization/fibrosis in patients with soft ...
ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA therapeutics, announced today that it will present initial Phase 1 clinical data for ADX ...
RNA COVID-19 vaccines — originally developed to protect against the coronavirus — may be providing an additional, unexpected health advantage.
Findings published in Nature Biomedical Engineering and presented at ESMO 2025 validate iOncologi's Universal Immune ...
What are nanoplastics, and how do environmental coatings help them evade your body's defenses? Find out the emerging health ...
Researchers at the ESMO Congress said they want to confirm their findings in a prospective randomized controlled trial.
Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in next-generation immunotherapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback